Abstract:CONTEXT: Prenylated caged xanthones are "privileged structure" characterized by the presence of the unusual 4-oxo-tricyclo[4.3.1.0(3,7)]dec-8-en-2-one scaffold. The natural sources of these compounds confines mainly in the Garcinia genus in the family of Guttiferae. Gambogic acid is the most abundant substance and most of the studies have been done on this compound, particularly as a new potential antitumor agent. The history, sources, structural diversity, and biological activities of these compounds are covered.OBJECTIVE: This review is written with the intention to provide additional aspects from what have been published of prenylated caged xanthones, including history, sources, structural diversity, and biological activities.METHODS: This review has been compiled using information from a number of reliable references mainly from major databases including SciFinder, ScienceDirect, and PubMed.RESULTS: More than 120 prenylated caged xanthones have been found in the plant genera Garcinia, Cratoxylum, and Dascymaschalon. These compounds exhibited various potentially useful biological activities such as anticancer, anti-HIV-1, antibacterial, anti-inflammatory, and neurotrophic activities.CONCLUSIONS: Prenylated caged xanthones, both naturally occurring and synthetic analogues, have been identified as promising bioactive compounds, especially for anticancer agents. Gambogic acid has been demonstrated to be a highly valuable lead compound for antitumor chemotherapy. The structure activity relationship (SAR) study of its analogues is still the subject of intensive research. Apoptosis cytotoxic mechanism has been identified as the major pathway. Research on the delineation of the in-depth mechanism of action is still on-going. Analogues of gambogic acid had been identified to be effective against a rare and special form of liver cancer, cholangiocarcinoma for which currently there is no chemotherapeutic treatment available.

Bioactive scalemic caged xanthones from the leaves of Garcinia bracteata.

Cytotoxic Prenylated Xanthones from the Leaves of Garcinia Bracteata

Caged Xanthones and Biphenyls Isolated from the Tropical Plant Garcinia lateriflora

Cytotoxic Caged Tetraprenylated Xanthonoids from Garcinia Gaudichaudii (Guttiferae)

Caged Polyprenylated Xanthones in Garcinia Hanburyi and the Biological Activities of Them

Cytotoxic Xanthone Derivatives from the Twigs of Garcinia Oligantha

Structural Diversity and Biological Activities of Caged Garcinia Xanthones: Recent Updates

Xanthone Derivatives from the Leaves of Garcinia Oligantha.

Cytotoxic 7‐Methoxylated Caged Xanthones from the Twigs of Garcinia oligantha

Acylphloroglucinol Derivatives with a Tricyclo-[4.4.1.11,4] Dodecane Skeleton from Garcinia Bracteata Fruits

Chemical Constituents from Leaves of Garcinia Xanthochymus

Cytotoxic Polyprenylated Xanthones from the Resin of Garcinia Hanburyi

Novel cytotoxic polyprenylated xanthonoids from Garcinia gaudichaudii (Guttiferae)

Isolation and antihyperglycemic effects of garcibractinols A–H, intricate polycyclic polyprenylated acylphloroglucinols from the fruits of Garcinia bracteata

A new xanthone isolated from Garcinia bracteata and its important effect on NO levels

Polyprenylated xanthones and benzophenones from the bark of Garcinia oblongifolia

Garcinia Xanthones As Orally Active Antitumor Agents

A new bixanthone derivative from the bark of Garcinia oblongifolia.

New α-glucosidase inhibitory xanthones from the fruits of Garcinia schomburgkiana

Recent Research on Bioactive Xanthones from Natural Medicine: Garcinia hanburyi

Prenylated caged xanthones: Chemistry and biology